N/A
N=51
Effect of Neural Mobilization on Lumbosacral Radiculopathy Patients With Peripheral Sensitization
Radiculopathy
Bottom Line
View on ClinicalTrials.gov: NCT03621878 ↗Enrolled (actual)
51
Serious AEs
0.0%
Results posted
Jul 2019
Primary outcome: Primary: Visual Analog Scale — 5.638; 5.050; 5.094; 4.894 Centimeters
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Neural mobilization exercises -Tensioner technique (Other); Neural mobilization exercises -Slider technique (Other); Transcutaneous Electrical Nerve Stimulation (TENS) (Other)
- Age
- Adult · 18+ yrs
- Sex
- Male
- Sponsor
- Mohammed Al-Ghamdi
- Primary completion
- Nov 2017
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Visual Analog Scale |
5.638; 5.050; 5.094; 4.894; 4.759; 3.576 | — |
| PRIMARY Hip Flexion Range of Motion (Symptomatic Side) |
51.82; 57.71; 46.29; 58.53; 63.59; 58.88 | — |
| PRIMARY Knee Flexion Range of Motion (Symptomatic Side) |
52.29; 45.647; 47.059; 49.41; 31.294; 34.824 | — |
| PRIMARY Hip Flexion Range of Motion (Asymptomatic Side) |
70.00; 71.824; 63.59; 69.41; 70.82; 69.12 | — |
| PRIMARY Knee Flexion Range of Motion (Asymptomatic Side) |
31.1176; 31.7059; 28.8824; 30.41; 24.06; 26.06 | — |
Summary
The primary purpose of this study was to investigate the effects of slider and tensioner techniques on pain, hip and knee ROM in lumbosacral radiculopathy patients with peripheral sensitization. A secondary purpose was to evaluate the correlation between these outcomes measurements.
Eligibility Criteria
Inclusion Criteria
- Patients with lumbosacral radiculopathy with dominant peripheral sensitization
- patients with unilateral leg pain.
- patient S-LANSS score > 12,
- negative sensory and motor examination.
- positive neural tissue provocation tests (straight leg raising test, slump test).
- adult.
- pain duration of more than 3 months.
Exclusion Criteria
- S-LANSS score ≥ 12,
- motor or sensory deficits,
- history of back or lower extremity surgeries,
- bilateral referred pain,
- patients with pacemakers, cardiovascular problems, epilepsy, active malignancy, dermatological conditions, and diminished pain sensation.
Data sourced from ClinicalTrials.gov (NCT03621878). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.